Achievements in heart mobile medical technology during the whole 2015

        2015 was a year of surprising all Yocaly’s persons. The number of cardiovascular patients served by Yocaly had break through 100,000 cases in its medical mobile monitoring history. Over 5000 patients’ lives were saved through early detection, indicating that we had taken a big step in prevention and control of cardiovascular events of social patients.

　　In 2015, Yocaly made strategic cooperation with Lepu Medical, the largest cardiovascular implantable device manufacturer in China, and completed the second financing. Yocaly also made excellent achievements in clinical scientific researches including screening of ischemic stroke in China conducted by Beijing Tiantan Hospital, Capital Medical Hospital, research on comprehensive prevention and control of coronary heart disease based on remote real-time monitoring technology conducted by Suzhou Center for Disease Prevention and Control.

　　We sincerely thank every cardiovascular specialist for your support and encouragement, all partners for your dedication to our performance. Yocaly’s persons from generation to generation continually put forward our heart mobile medical technology, ECG algorithm, and data cloud platform technology according to the tenet “supreme life, striving for perfection”.

　　Abnormal ECG information may threaten the lives of patients. Yocaly devoted to heart mobile medical service, timely detection of abnormal ECG data, rapidly pre-warning, shortening the treatment time of patient and supporting hospitals and clinical doctors for rescuing more high-risk patients.

　　In 2015, Yocaly had served 327 hospitals at all levels, covering 24 provinces and municipalities in the country;

　　In 2015, Yocaly had seved 104,250 cases of patients, and the number of patients had first break through 100,000 cases.

　　In 2015, Yocaly had analyzed 4440870 copies of real-time data processing, and 104,250 copies of 24 hours of dynamic data;

　　In 2015, 5280 high-risk patients were early detected and their lives were saved.

　　In 2015, the strategic cooperation was made with Lepu Medical, the largest cardiovascular implantable device manufacturer in China, so as to create an industrial chain from screening of cardiovascular events, drug intervention therapy, to monitoring during rehabilitation period.

　　In 2015, Dr. Wang Bo had completed the three-year program “research on comprehensive prevention and control of coronary heart disease based on remote real-time monitoring technology ", and achieved the enough experience in administration of rehabilitation services of coronary heart disease

　　In 2015, the three-year program “screening of ischemic stroke in China ”conducted by Beijing Tiantan Hospital, Capital Medical Hospital provided a powerful technology in early screening of ischemic stroke

　　In 2015, the data cloud platform had stored over 15,000,000 copies of various ECG data, and the number continued to grow.

　　For ten years, Yocaly was standing in the forefront of technology development and realizing commitment to customers according to the tenet “supreme life, striving for perfection”.